Addressing formulation issues of syariah compliant generic sustained release antidiabetic solid dosage form.
Gliclazide (1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea) is a second-generation sulfonylurea which is orally administered in the treatment of non-insulin-dependent diabetes mellitus in adults. Sustain release drugs help to improve drugs bioavailability by c...
| Main Authors: | Mohd Nawi, Mohamed Sufian, Abul Bashar Mohammed, Helaluddin, Kasmuri, Abdul Razak, Tan, Soo Choon |
|---|---|
| Format: | Monograph |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/63437/ http://irep.iium.edu.my/63437/1/Research%20Completion%20Report%20RIGS%2015-090-0090_SUFIAN.pdf |
Similar Items
-
Preliminary study on the formulation of syariah
compliant generic sustained release gliclazide tablet
using xanthan gum
by: Mat Zin, Nik Mohamad Lukman, et al.
Published: (2018) -
Combination of xanthan gum and HPMC as retardants in sustained release gliclazide formulation
by: Othman, Liyana Zafirah, et al.
Published: (2017) -
Bio-analytical method development of generic formulations manufactured at IIUM Pharmaceutical manufacturing plant
by: Helaluddin, Abul Bashar Mohammed
Published: (2017) -
Development and validation of LC-MSMS method for the analysis of amlodipine and perindopril in tablet dosage form
by: Alaama, Mohamed, et al.
Published: (2018) -
Current analytical methods for amlodipine and its formulations: A review
by: Helaluddin, Abul Bashar Mohammed, et al.
Published: (2017)